<DOC>
	<DOCNO>NCT01924429</DOCNO>
	<brief_summary>The purpose study determine effect Vyvanse , FDA approve medication use treatment Attention Deficit Hyperactivity Disorder ( ADHD ) , brain activity adult attention-deficit hyperactivity disorder ( ADHD ) . Participants may qualify participation study ADHD willing participate two Functional Magnetic Resonance Imaging ( fMRI ) scan receive Vyvanse treatment symptom . Another purpose study collect bank sample blood research examine gene influence brain activation see brain scan . The study also seek find whether certain gene relate ADHD . Participants ' entire genetic makeup determine sample .</brief_summary>
	<brief_title>Neurobiological Basis Response Vyvanse Adults With ADHD : fMRI Study Brain Activation</brief_title>
	<detailed_description />
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Primary DSMIVTR diagnosis adult ADHD ( inattentive , hyperactiveimpulsive combine subtype ) , establish via ACDS v1.2 . Must 1855 year , inclusive . Provides write informed consent . Lifetime current diagnosis bipolar disorder , schizophrenia schizoaffective disorder . Current diagnosis comorbid major depressive disorder , anxiety disorder dysthymia control ( i.e . require pharmacological treatment ) comorbid diagnosis . Participants uncontrolled depressive anxiety disorder may participate , opinion Principal Investigator , disorder confound result efficacy safety assessment , increase risk participant lead difficulty comply protocol . Meets current DSMIVTR criterion alcohol nonalcohol substance abuse dependence disorder . Have organic brain disease ( dementia ) traumatic brain injury residuum . Have history seizure disorder ( febrile seizure ) participant take ( currently take ) anticonvulsant seizure control . Females currently pregnant breast feeding , woman childbearing potential currently use adequate form birth control . Participants clinically significant abnormality ECG result deem exclusionary opinion Principal Investigator allow trial . Participants work night shift another schedule would preclude begin daily dose study medication morning . Participants positive urine drug result Screening . Medical condition limit participation study . Documented history intolerance nonresponsivity methylphenidate amphetamine . Have medical condition would , opinion study physician , make participation medically hazardous . ADHD , Not Otherwise Specified History surgery involve metal implant , metal fragment eye , brace , pacemaker .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>ADHD</keyword>
	<keyword>fMRI</keyword>
	<keyword>Imaging</keyword>
	<keyword>Vyvanse</keyword>
	<keyword>Stimulant Medication</keyword>
	<keyword>Treatment</keyword>
	<keyword>Clinical Trial</keyword>
	<keyword>Adult</keyword>
</DOC>